Affinia Therapeutics Inc. — Form D
Affinia Therapeutics Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-14. The offering totals $45.0M, of which $13.3M was reported sold. Industry: Other.
Offering
- Filed: 2025-10-14
- Form: D
- Accession: 0001231919-25-000313
- Industry: Other
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $13.3M
- Remaining: $31.7M
- Investors: 20
- Date of first sale: 2025-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-560739
Issuer
- Name: Affinia Therapeutics Inc.
- CIK: 0001792694
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 43 FOUNDRY AVE, SUITE 120, WALTHAM, MA, 02453
- Phone: 617-430-7817
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Diana Brainard | Director | WALTHAM, MA |
| Carole Faig | Director | WALTHAM, MA |
| David Grayzel | Director | Cambridge, MA |
| Edward Mathers | Director | South San Francisco, CA |
| Rick Modi | Director | WALTHAM, MA |
| Sean Nolan | Director | WALTHAM, MA |
| Elliott Sigal | Director | WALTHAM, MA |
| Luc Vandenberghe | Director | WALTHAM, MA |
| Robert Weisskoff | Director | Foster City, CA |
| Rami Daoud | Executive Officer | WALTHAM, MA |
| Rick Modi | Executive Officer | WALTHAM, MA |
| ROBERT JOHNSON | Executive Officer | East Lansing, MI |
| Rob May | Executive Officer | Boston, MA |
| Laura Richman | Executive Officer | Waltham, MA |
| Petra Kaufmann | Executive Officer | Waltham, MA |
| Robert Aboud | Executive Officer | Waltham, MA |
| Paula Cobb | Executive Officer | Waltham, MA |
| Caroline Stout | Director | Waltham, MA |
| Elliot Sigal | Director | Waltham, MA |
| Charles Albright | Executive Officer | Waltham, MA |
| Luk Vandenberghe | Director | Cambridge, MA |
Other filings by this issuer (3)
More